Dergiler / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 4

Retinal Makroanevrizmanın Tedavisinde İntravitreal Afl ibercept’in Etkinliği

Effectiveness of Intravitreal Afl ibercept in the Treatment of Retinal Macroaneurysm

Sayfa
381–384
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

İntravitreal afl ibercept semptomatik RAM için alternatif ve etkin bir tedavi yöntemi olabilir.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:RAP (Retinal Anjiomatöz Proliferasyon) seyri sırasından tesadüfen saptanan semptomatik retinal makroanevrizmanın (RAM) intravit- real afl iberceptin etkisi ile kapanmasını göstermek için olgunun sunulması amaçlanmıştır. 76 yaşındaki erkek hastanın kontrol muaye- nesinde üst temporal arter de makroanevrizma ve makulayı da içine alan retina ödem saptandı.
📊
Temel Bulgular & Veri:Hastaya 3 doz intravitreal afl ibercept tedavisi uygulandı.
💡
Sonuç & Katkı:İntravitreal afl ibercept semptomatik RAM için alternatif ve etkin bir tedavi yöntemi olabilir.
🔬Tür:Deneysel Tarla Denemesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

RAP (Retinal Anjiomatöz Proliferasyon) seyri sırasından tesadüfen saptanan semptomatik retinal makroanevrizmanın (RAM) intravit- real afl iberceptin etkisi ile kapanmasını göstermek için olgunun sunulması amaçlanmıştır. 76 yaşındaki erkek hastanın kontrol muaye- nesinde üst temporal arter de makroanevrizma ve makulayı da içine alan retina ödem saptandı. Hastaya 3 doz intravitreal afl ibercept tedavisi uygulandı. Tedavi sonrası ödemin kaybolduğu ve RAM’ın tamamen kapanmış olduğu izlendi. En iyi düzeltilmiş görme keskin- liği 3/10 ‘dan 3 doz intravitreal afl ibercept enjeksiyonu sonrası 7/10’a yükseldi. Oküler veya sistemik yan etki saptanmadı. İntravitreal afl ibercept tedavisi, RAM’ın kapanmasına, gelişmiş olan ödemin gerileyerek kaybolmasına ve dolayısı ile görme artışına neden olabilir. İntravitreal afl ibercept semptomatik RAM için alternatif ve etkin bir tedavi yöntemi olabilir.

Abstract

It is aimed to present a case to demonstrate that the incidental symptomatic retinal macroaneurysm is closed by the effect of intravitreal afribercept. Seventy-six-year-old male patient which was under follow-up for age-related macular degeneration in the retina department presented with retinal edema covering aIt is aimed to present a case to demonstrate that the incidental symptomatic retinal macroaneurysm is closed by the effect of intravitreal afribercept. Seventy-six-year-old male patient which was under follow-up for age-related macular degeneration in the retina department presented with retinal edema covering all macular area due to a macroaneurysm in the superior temporal branch of the retinal artery. The patient was treated with 3 consecutive monthly injections of intravitreal afl ibercept. Macular edema was observed to gradually de- creased with complete closure of the RAM after the treatment. The best corrected visual acuity improved from 3/10 at baseline to 7/10 after the treatment. Ocular or systemic side effect was not observed. Intravitreal afl ibercept can provide closure of RAM, disappearance of macular edema by gradual resolution and hence improvement of visual acuity. Intravitreal afl ibercept may be an alternative and ef- fective treatment for symptomatic RAM.ll macular area due to a macroaneurysm in the superior temporal branch of the retinal artery. The patient was treated with 3 consecutive monthly injections of intravitreal afl ibercept. Macular edema was observed to gradually de- creased with complete closure of the RAM after the treatment. The best corrected visual acuity improved from 3/10 at baseline to 7/10 after the treatment. Ocular or systemic side effect was not observed. Intravitreal afl ibercept can provide closure of RAM, disappearance of macular edema by gradual resolution and hence improvement of visual acuity. Intravitreal afl ibercept may be an alternative and ef- fective treatment for symptomatic RAM.

🔖

Bu Makaleye Atıf Yap

ERTAN, E., İNAN, S., İNAN, Ü. Ü. (2018). Retinal Makroanevrizmanın Tedavisinde İntravitreal Afl ibercept’in Etkinliği. Retina-Vitreus, Cilt: 27 - Sayı: 4, 381–384. https://ajindex.com/articles/308127

Kaynakça (13)

  1. Rabb MF, Gagliano DA, Tesk MP. Retinal arterial macroaneurys- ms. SurvOphthalmol 1988;33:73-96
  2. Panteon RW, Goldberg MF, Farber MD.Retinal arterial mac- roaneurysms Risk factors and natural history.Br J Ophthalmol 1990;74:595-600
  3. Chew EY, Murphy PR. Acquired retinal macroaneurysms. In Ryan SJ, ed. Retina, St Louis, Mosby 2001;86:1500-4
  4. Takahashi K, Kishi S. Serous macular detachment associated with retinal arterial macroaneurysm. Jpn J Ophthalmol 2006;50:460-4
  5. Cleary PE, Kohner EM, Hamilton AM, Bird AC. Retinal macroa- neurysms. Br J Ophthalmol 1975;59:355-61
  6. Ohno-Matsui K, Hayano M, Futagami S, Tokoro T, Ohno S. Spon- taneous involution of a large retinal arterial macroaneurysm. Acta- Ophthalmol Scand 2000;78:114-7
  7. Brown DM, Sobol WM, Folk JC, Weingeist TA. Retinal arteriolar macroaneurysms: Long-term visual outcome. Br J Ophthalmol. 1994;78:534–8
  8. Koinzer S, Heckmann J, Tode J, Roider J: Long-term, therapy-re- lated visual outcome of 49 cases with retinal arterial macro- aneurysm: A case series and literature review. Br J Ophthalmol 2015;99:1345–53
  9. Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of Anti-Vascular Endothelial Growth Factor use in Ophthalmology among privately insured and medicare ad- vantage patients. Ophthalmology 2016;S0161-6420(16)31834-6
  10. Chanana B, Azad RV. Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm. Eye (Lond) 2009;23:493- 494 Golan S, Goldenberg D, Goldstein M. Long-term follow-up ofi nt- ravitreal bevacizumab in retinal arterial macroaneurysm:a case report. Case Report Ophthalmol 2011;2:387-91
  11. Cho HJ, Rhee TK, Kim HS, Han JI, Lee DW, Cho SW, Kim JW. Intravitreal bevacizumab for symptomatic retinal arterial macroa- neurysm. Am J Ophthalmol. 2013;155:898-904
  12. Pichi F, Morara M, Torrazza C, Manzi G, Alkabes M, Balducci N, Vitale L, Lembo A, Ciardella AP, Nucci P. Intravitreal bevacizu- mab for macular complications from retinal arterial macroaneurys- ms. Am J Ophthalmol. 2013;155:287-94
  13. Wenkstern AR, Petersen H. Intravitreal ranibizumab in retinal mac- roaneurysm. Graefes Arch ClinExpOphthalmol 2010;248:1667-70 Kishore K. Long-Term Management of Complications of Retinal Artery Macroaneurysms with Intravitreal Afl ibercept Injection. Case RepOphthalmol 2016;7:162-71